Investigation of the Relationship Between Shoulder Alpha Angle and Humeral Head Displacement Percentage Measured by Ultrasonography in Neonatal Brachial Plexus Palsy Infants With Clinical Parameters
2026年8月12日 更新者:Fatih Sultan Mehmet Training and Research Hospital
This study will examine infants with a birth-related nerve injury called neonatal brachial plexus palsy, which can affect movement in the arm and sometimes cause the shoulder joint to shift out of its normal position (subluxation).
Researchers will use ultrasound imaging to measure the shoulder joint and will compare these measurements with findings from a physical examination, to determine which clinical signs can help predict whether a baby's shoulder will develop this problem.
The goal is to help doctors detect shoulder problems earlier, so that treatment can start sooner.
研究概览
地位
尚未招聘
详细说明
Infants aged 3 months to 1 year with neonatal brachial plexus injury (Narakas Group I-III) will be evaluated at a single pediatric rehabilitation clinic.
At each visit, the same physiatrist will perform a standardized clinical examination, including assessment of demographic and obstetric history, subluxation-specific clinical signs (axillary skin fold asymmetry, palpable posterior fullness), passive range of motion, upper extremity length discrepancy, the Active Movement Scale, and the Toronto Test Score.
A second physiatrist, blinded to clinical findings, will perform shoulder ultrasonographic evaluation using a posterior approach to measure the alpha angle and the percentage of humeral head displacement (PHHD).
Glenohumeral subluxation will be defined as an alpha angle greater than 30 degrees; dislocation will be defined as an alpha angle greater than 30 degrees combined with PHHD greater than 50%.
Associations between clinical findings and ultrasonographic subluxation will be analyzed using Generalized Linear Mixed Models to account for repeated measurements per patient, followed by ROC curve analysis to identify optimal predictive thresholds.
研究类型
观察性的
注册 (估计的)
19
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习联系方式
- 姓名:Melike Nur Rençber, MD
- 电话号码:+90 553 770 28 43
- 邮箱:melibalat@gmail.com
研究联系人备份
- 姓名:Esra Giray, MD
- 电话号码:+90 555 813 43 94
- 邮箱:girayesra@hotmail.com
学习地点
-
-
-
Istanbul、土耳其(türkiye)、34668
- University of Health Sciences Turkey, Fatih Sultan Mehmet Training and Research Hospital
-
首席研究员:
- Esra Giray, MD
-
接触:
- Melike Nur Rençber, MD
- 电话号码:+90 553 770 28 43
- 邮箱:melibalat@gmail.com
-
接触:
- Esra Giray, MD
- 电话号码:+90 555 813 43 94
- 邮箱:girayesra@hotmail.com
-
副研究员:
- Melike Nur Rençber, MD
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
不
取样方法
非概率样本
研究人群
Infants diagnosed with neonatal brachial plexus injury who present to the Pediatric Rehabilitation Clinic of the University of Health Sciences Turkey, Fatih Sultan Mehmet Training and Research Hospital, and who meet the eligibility criteria, will be consecutively enrolled in the study
描述
Inclusion Criteria:
- Diagnosis of neonatal brachial plexus injury (NBPI) between 3 months and 1 year of age
- Narakas classification Group I, II, or III
- Absence of nerve root avulsion
Exclusion Criteria:
- Prior shoulder surgery for NBPI
- Inability to tolerate ultrasonographic examination
- Concomitant musculoskeletal (e.g., torticollis, humeral fracture) or neurological disease
- Bilateral NBPI
- Narakas classification Group IV
- Botulinum toxin injection to the affected shoulder
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Infants with Neonatal Brachial Plexus Palsy
Infants aged 3 months to 1 year with neonatal brachial plexus injury (Narakas Group I-III) who will undergo standardized clinical examination and shoulder ultrasonographic evaluation at each visit.
|
Ultrasonographic measurement of the shoulder alpha angle and percentage of humeral head displacement (PHHD), to be performed at each clinical visit.
Standardized physical examination including passive range of motion, Active Movement Scale, Toronto Test Score, and subluxation-specific clinical signs, to be performed at each visit.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Ultrasonographic Alpha Angle
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
Alpha angle will be measured sonographically at each shoulder examination.
Glenohumeral subluxation will be defined as an alpha angle greater than 30 degrees.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
|
Percentage of Humeral Head Displacement (PHHD)
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
PHHD will be measured sonographically at each shoulder examination.
Glenohumeral dislocation will be defined as an alpha angle greater than 30 degrees combined with PHHD greater than 50%.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Passive Range of Motion of the Shoulder and Elbow
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
Passive range of motion of the shoulder (flexion, extension, abduction, internal and external rotation) and elbow (flexion, extension) will be measured using standard goniometry at each visit and evaluated for association with glenohumeral subluxation.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
|
Active Movement Scale (AMS) Score
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
AMS score will be assessed at each visit as a clinical predictor of glenohumeral subluxation.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
|
Toronto Test Score
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
Toronto Test Score will be calculated at each visit and evaluated for association with glenohumeral subluxation.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
|
Subluxation-Specific Clinical Signs (Axillary Skin Fold Asymmetry and Palpable Posterior Fullness)
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
Presence of axillary skin fold asymmetry and palpable posterior shoulder fullness will be assessed at each visit and evaluated for association with glenohumeral subluxation.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
|
Upper Extremity Length Discrepancy
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
Difference in upper extremity length between the affected and unaffected sides will be measured at each visit and evaluated for association with glenohumeral subluxation.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
|
Reinnervation Status
大体时间:Assessed at each clinical visit from 3 months to 1 year of age
|
Neurological reinnervation status (full, partial, or none) will be assessed at each visit relative to the prior visit.
|
Assessed at each clinical visit from 3 months to 1 year of age
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年8月1日
初级完成 (估计的)
2027年8月1日
研究完成 (估计的)
2027年11月1日
研究注册日期
首次提交
2026年8月12日
首先提交符合 QC 标准的
2026年8月12日
首次发布 (实际的)
2026年8月17日
研究记录更新
最后更新发布 (实际的)
2026年8月17日
上次提交的符合 QC 标准的更新
2026年8月12日
最后验证
2026年8月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 24/648
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
未定
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.